menu
    • menu

    Company profile for Vascarta

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vascarta is focused on innovative approaches to improving vascular health. Their work combines advanced scientific research and clinical expertise to provide therapies aimed at treating vascular conditions. They prioritize collaboration with healthcare providers and researchers to ensure effective solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VascartaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Town & Country Pharmacy 535 East Crescent Ave Ramsey, NJ 07446
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vascarta.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Study: VAS-101 Boosts Cardiac Function in SCD Mouse Model
    FDA Study: VAS-101 Boosts Cardiac Function in SCD Mouse Model

    03 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/novel-transdermal-curcumin-vas-101-improves-cardiac-mitochondrial-function-in-sickle-cell-disease-mouse-model-new-fda-led-study-shows-302631144.html

    PR NEWSWIRE
    03 Dec 2025
    Share Share
    Vascarta & CUNY Achieve Preclinical Glioblastoma Treatment
    Vascarta & CUNY Achieve Preclinical Glioblastoma Treatment

    10 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-and-cuny-report-preclinical-breakthrough-in-glioblastoma-treatment-302608991.html

    PR NEWSWIRE
    10 Nov 2025
    Share Share
    Vascarta Interrupts Neuroinflammatory Cascade In Acute Sickle
    Vascarta Interrupts Neuroinflammatory Cascade In Acute Sickle

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-inc-transdermal-curcumin-vas-101-drug-candidate-interrupts-the-neuroinflammatory-pathophysiological-cascade-associated-with-acute-sickle-cell-crisis-302602960.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Vascarta Completes Phase 1 Trial Of VAS-101 For Osteoarthritis
    Vascarta Completes Phase 1 Trial Of VAS-101 For Osteoarthritis

    29 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-announces-completion-of-phase-1-clinical-trial-of-vas-101-for-the-treatment-of-osteoarthritis-302569072.html

    PR NEWSWIRE
    29 Sep 2025
    Share Share
    Vascarta Adds Dr. Janet Loesberg to Leadership Team
    Vascarta Adds Dr. Janet Loesberg to Leadership Team

    28 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vascarta-announces-addition-of-dr-janet-loesberg-to-leadership-team-302514988.html

    PR NEWSWIRE
    28 Jul 2025
    Share Share
    Vascarta Partners with NIH for Phase 1 study of VAS-101
    Vascarta Partners with NIH for Phase 1 study of VAS-101

    07 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/national-heart-lung-and-blood-institute--national-institutes-of-health-signs-clinical-trial-agreement-with-vascarta-inc-to-perform-phase-1-clinical-study-of-vas-101-in-sickle-cell-disease-302498504.html

    PR NEWSWIRE
    07 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search